Advertisement

Down-regulation of Dopamine Autoreceptors by Estrogens: Physiological Control

  • M. P. Piccardi
  • G. Martis
  • S. Mulas
  • G. U. Corsini
Part of the Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology book series (SSNIC)

Abstract

Many studies have demonstrated an effect of estrogenic compounds on central dopaminergic activity. Some clinical observations have shown that both an increase of endogenous estrogens, as observed during pregnancy, and the oral administration of synthetic estrogenic compounds, as during oral contraceptive treatment, may induce extrapyramidal disorders. Choreatic movements have been described during oral contraception by several authors (3,16,19, 28, 32, 36) and in 1978 Donaldson (14) reviewed the cases of abnormal movements associated with pregnancy. Moreover, it has been reported that estrogen treatment improves L-DOPA induced dyskinesias in parkinsonian patients (6,7), worsens the neuroleptic-induced parkinsonian syndrome (22) and markedly ameliorates tardive dyskinesia (6, 7, 43, 44).

Keywords

High Performance Liquid Chromatography Estrous Cycle Tardive Dyskinesia Estrogen Treatment Endogenous Estrogen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abraham G.E., Manlimos F.S., Garza R. (1977): Radioimmunoassay of steroids. In: Handbook of radioimmunoassay, eds. G.E.Abraham, M. Dekker Inc., New York, U.S.A., pp.590.Google Scholar
  2. 2.
    Ball P., Knuppen R., Haupt M. and Breur H. (1972): Interactions between estrogens and catecholamines: Studies on the methylation of catechol estrogens, catecholamines and other catechols by catechol-o-methyltransferase of human liver. J.Clin.Endocrinol. Metab. 34, 736 – 746.PubMedCrossRefGoogle Scholar
  3. 3.
    Barber P.V., Arnold A.G. and Evans G. (1976): Recurrent hormone dependent chorea: effects of estrogens and progestogens. Clin. Endocrinol. 5, 291 – 293.CrossRefGoogle Scholar
  4. 4.
    Beatty W.W. and Holzer G.A. (1978): Sex differences in stereotyped behaviour in the rat. Pharmacol.Biochem.Behav. 9, 777 – 783.PubMedCrossRefGoogle Scholar
  5. 5.
    Bedard P., Dankova J., Boucher R. and Langelier P. (1978): Effect of estrogens on apomorphine-induced circling behaviour in the rat. Can.J.Physiol.Pharmacol. 56, 538 – 541.PubMedCrossRefGoogle Scholar
  6. 6.
    Bedard P., Langelier P., Dankova J., Villeneuve A., Di Paolo T., Barden N., Labrie F., Boissier J.R. and Euvrard C. (1979): Estrogens, progesterone and the extrapyramidal system. In: Extrapyramidal system and its disorders, eds: L.J.Poirier, T.L.Sourkes and P.Bedard, Raven Press, New York, pp.411 – 422.Google Scholar
  7. 7.
    Bedard P., Langelier P. and Villenenuve A. (1977): Estrogens and extrapyramidal system. Lancet 2, 1367 – 1368.PubMedCrossRefGoogle Scholar
  8. 8.
    Carlsson A. (1975): Receptor-mediated control of dopamine metabolism. In: Pre-and Post-synaptic receptors, eds.E.Usdin and W.E. Bunney Jr., Marcel Dekker, New York, pp.49 – 65.Google Scholar
  9. 9.
    Chiodo L.A. and Antelman S.M. (1980b): Repeated tricyclics induce a progressive dopmaine autoreceptor subsensitivity independent of daily drug treatment. Nature 287, 451 – 454.PubMedCrossRefGoogle Scholar
  10. 10.
    Chiodo L.A. and Caggiula A.R. (1980a): Alterations in basal firing rate and autoreceptor sensitivity of dopamine neurons in the substantia nigra following acute and extended exposure to estrogen. Eur.J.Pharmacol. 67, 165 – 166.PubMedCrossRefGoogle Scholar
  11. 11.
    Chiodo L.A., Caggiula A.R. and Saller C.F. (1980c): Estrogen potentiates the stereotypy induced by dopamine agonists in the rat. Life Sci. 28, 82è – 835.Google Scholar
  12. 12.
    Conney A.H. (1971): Environmental factors influencing drug metabolism. In: Fundamentals of drug metabolism and drug dispersion, eds. B.M.La Der, H.G.Mandel and E.L.Way, Williams and Williams, Baltimore, pp.253 – 278.Google Scholar
  13. 13.
    Coppen A. and Kessel N. (1983): Menstruation and personality, Br. J.Psychiatry 109, 711 – 721.CrossRefGoogle Scholar
  14. 14.
    Donaldson J.O. (1978): In: Neurology of Pregnancy, W.B.Saunders Co., Philadelphia, pp.74 – 87.Google Scholar
  15. 15.
    Euvrard C., Oberlander C. and Boissier J.R. (1980): Antidopaminergic effect of estrogens at the striatal level. J.Pharmacol. Exp.Ther. 214, 179 – 185.PubMedGoogle Scholar
  16. 16.
    Fernando S.J.M. (1966): An attack of chorea complicating oral contraceptive therapy. Practitioner 197, 210 – 211.PubMedGoogle Scholar
  17. 17.
    Fields J.Z., Callahan M.F. and Gordon J.H. (1980): Effect of estrogens on the development and expression of dopamine receptor supersensitivity. Abs.Soc.NeuroSci. 6, 255.Google Scholar
  18. 18.
    Flemenbaum A. (1979): Rat dopaminergic hypersensitivity. II, Effects of sex. Neuropsychobiology 2, 222.CrossRefGoogle Scholar
  19. 19.
    Gamboa E.T., Isaacs G. and Harter D. (1971): Chorea associated with oral contraceptive therapy. Arch.Neurol. 25, 112 – 114.PubMedCrossRefGoogle Scholar
  20. 20.
    Gordon J.H. (1980): Modulation of apomorphine-induced stereotypy by estrogen: time-course and dose-response. Brain Res.Bull. 5, 679 – 682.PubMedCrossRefGoogle Scholar
  21. 21.
    Gordon J.H., Gorski R.A., Borison R.L. and Diamond B.I. (1980): Postsynaptic efficacy of dopamine: possible suppression by estrogen. Pharmacol.Biochem.Behav. 12, 515 – 518.PubMedCrossRefGoogle Scholar
  22. 22.
    Gratton L. (1960): Neuroleptiques, parkinsonisme et schizophrénie. Union Med.Can. 89, 681 – 694.Google Scholar
  23. 23.
    Hruska R.E., Ludmer L.M. and Silbergeld E.K., 1980. Characterization of the striatal dopamine receptor supersensitivity produced by estrogen treatment of male rats. Neuropharmacology 19, 923 – 926.PubMedCrossRefGoogle Scholar
  24. 24.
    Hruska R.E. and Silbergeld E.K. (1980): Estrogen treatment enhan dopamine receptor sensitivity in the rat striatum. Eur.J. Pharmacol. 61, 397 – 400.PubMedCrossRefGoogle Scholar
  25. 25.
    Hruska R.E. and Silbergeld E.K. (1980): Increased dopamine recep tor sensitivity after estrogen treatment using the rat striatum rotation model. Science 208, 1466 – 1468.PubMedCrossRefGoogle Scholar
  26. 26.
    Koller W.C., Weiner W.J., Klawans H.L. and Nausieda P.A. (1980): Influence of female sex hormones on neuroleptic induced behavioural supersensitivity. Neuropharmacology 19, 387.PubMedCrossRefGoogle Scholar
  27. 27.
    Labrie F., Beaulieu H., Raymond D.V., Di Paolo T., Caron M., Veilleux R., Denizeau F., Euvrard C., Raynaud J.P. and Boissier J.R. (1979): Control of prolactin secretion at the pituitary level: a model for postsynaptic dopaminergic systems. In: Effect of hypothalamic hormones and other peptides, eds.R.Collu, Raven Press, New York, pp.207 – 234.Google Scholar
  28. 28.
    Labrie F., Di Paolo T., Raymond V., Ferland L. and Beaulieu M. (1980): The pituitary dopamine receptor. In: Ergot compounds and brain function: Neuroendocrine and neuropsychiatric aspects, eds. M.Goldstein, D.B.Calne, A.N.Lieberman and M.O.Thorner, Raven Press, New York, pp.217.Google Scholar
  29. 29.
    Lewis P.D. and Harrison M.J.G. (1969): Involuntary movements in patients taking oral contraceptives. Neurology 29, 1605 – 1609.Google Scholar
  30. 30.
    Masur J., Boerngen R. and Tufik S. (1980): Sex differences in the response to apomorphine in rats. Pharmacology 20, 160 – 165.PubMedCrossRefGoogle Scholar
  31. 31.
    Meyer E. (1977): Age and sex related differences in amphetamine induced locomotor activity. Fed.Proc. 36, 1033.Google Scholar
  32. 32.
    Mislow J.F. and Friedhoff A.J. (1973): A comparison of chlorpromazine-induced extrapyramidal syndrome in male and female rats. In: Hormones and Brain Function, eds. K.Lissak, Plenum Press, New York, pp. 315 – 326.Google Scholar
  33. 33.
    Nausieda P.A., Koller W.C., Weiner W.J. and Klawans H.L. (1979): Chorea induced by oral contraceptives. Neurology 29, 1605 – 1609.PubMedCrossRefGoogle Scholar
  34. 34.
    Piccardi M.P., Bernardi F., Rossetti Z. and Corsini G.U. (1983): Effect of estrogens on dopamine autoreceptors in male rats. Eur. J.Pharmac. 91, 1 – 9.CrossRefGoogle Scholar
  35. 35.
    Piccardi M.P., Bernardi F., Bocchetta A. and Corsini G.U. (1983): Estrogen modulation of dopaminomimetic actions: implications for autoreceptor regulation. In: Lisuride and other dopaminomimetics, eds. D.B.Calne et al, Raven Press, New York, pp.55 – 63.Google Scholar
  36. 36.
    Raymond V., Beaulieu H., Labrie F. and Boissier J.R. (1978): Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 200, 1173 – 1175.PubMedCrossRefGoogle Scholar
  37. 37.
    Riddoch D., Jefferson M. and Bickerstaff E.R. (1971): Chorea and the oral contraceptives. Br.Med.J. 4, 217 – 218.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Robinson T.E., Becker J.B. and Ramirez V.D. (1980): Sex differen ces in amphetamine-elicited rotational behaviour and the lateralization of striatal dopamine in rats. Brain Res.Bull. 5, 539 – 541.PubMedCrossRefGoogle Scholar
  39. 39.
    Robinson T.E., Camp D.M. and Becker J.B. (1981): Gonadectomy attenuates turning behaviour produced by electrical stimulation of the nigrostriatal dopamine system in female but not in male rats. NeuroSci Lett. 23, 203 – 208.PubMedCrossRefGoogle Scholar
  40. 40.
    Schneider B.F. and Norton S. (1979): Circadian and sex differences in hyperactivity produced by amphetamine in rats. Physiol. Behav. 22, 47 – 51.PubMedCrossRefGoogle Scholar
  41. 41.
    Steiner M., Kats R.J. and Carroll B.J. (1980): Behavioural effects of dopamine agonists across the estrous cycle in rats. Psycho-pharmacology 71, 147 – 151.CrossRefGoogle Scholar
  42. 42.
    Strombom U. (1976): Catecholamine receptor agonists. Effect on motor activity and rate tyrosine hydroxylation in mouse brain. Arch.Pharmacol. 292, 167.CrossRefGoogle Scholar
  43. 43.
    Villeneuve A., Cazejust T. and Coté M. (1980): Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology 6, 145 – 151.PubMedCrossRefGoogle Scholar
  44. 44.
    Villeneuve A., Langelier P. and Bedard P. (1978): Estrogens, dopamine and dyskinesias. Can.Psychiat.Assoc. 23, 68 – 70.Google Scholar
  45. 45.
    Winer B. (1971): In: Statistical Principles in Experimental Design, McGraw Hill, New York.Google Scholar

Copyright information

© The Contributors 1986

Authors and Affiliations

  • M. P. Piccardi
  • G. Martis
  • S. Mulas
  • G. U. Corsini

There are no affiliations available

Personalised recommendations